Invesco Ltd. Amgen Inc Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Invesco Ltd. holds 3,273,762 shares of AMGN stock, worth $1.05 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,273,762

Previous 3,096,507 5.72%

Holding current value

$1.05 Billion

Previous $880 Million 16.18%

% of portfolio

0.22%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $46.6 Million - $56.6 Million	177,255 Added 5.72%	3,273,762 $1.02 Billion
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $104 Million - $126 Million	-388,335 Reduced 11.14%	3,096,507 $880 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $32.9 Million - $37.1 Million	128,483 Added 3.83%	3,484,842 $1 Billion
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $100 Million - $125 Million	459,340 Added 15.86%	3,356,359 $902 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $58.6 Million - $69.3 Million	-273,593 Reduced 8.63%	2,897,019 $643 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $88.3 Million - $108 Million	390,917 Added 14.06%	3,170,612 $766 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $35.7 Million - $45.4 Million	156,028 Added 5.95%	2,779,695 $730 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $22.2 Million - $25.1 Million	-99,099 Reduced 3.64%	2,623,667 $591 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $15.7 Million - $17.5 Million	-67,978 Reduced 2.44%	2,722,766 $662 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $75.6 Million - $83.7 Million	344,875 Added 14.1%	2,790,744 $675 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $106 Million - $121 Million	533,328 Added 27.89%	2,445,869 $550 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $40.9 Million - $47.9 Million	192,511 Added 11.19%	1,912,541 $407 Million
Q2 2021 Aug 17, 2021	SELL	$233.58 - $259.14 $107 Million - $118 Million	-456,406 Reduced 20.97%	1,720,030 $419 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.37 Million - $1.59 Million	6,160 Added 0.28%	2,176,436 $542 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $219 Million - $261 Million	-1,011,596 Reduced 31.79%	2,170,276 $499 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $202 Million - $225 Million	861,772 Added 37.14%	3,181,872 $809 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $103 Million - $126 Million	519,744 Added 28.87%	2,320,100 $547 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $27.9 Million - $37 Million	153,003 Added 9.29%	1,800,356 $365 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $1.04 Billion - $1.34 Billion	-5,513,983 Reduced 77.0%	1,647,353 $397 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $61.2 Million - $73.3 Million	-351,289 Reduced 4.68%	7,161,336 $1.39 Billion
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $57.9 Million - $67.8 Million	-347,101 Reduced 4.42%	7,512,625 $1.38 Billion
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $44.2 Million - $49.8 Million	244,502 Added 3.21%	7,859,726 $1.49 Billion
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.36 Billion - $1.59 Billion	7,615,224 New	7,615,224 $1.48 Billion

Others Institutions Holding AMGN

# of Institutions

3,085

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.11M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account